- Original Poster
- #1
Hi
Last financial year we used a new accounting and stock management system which calculates stock valuation in a way that I'm not happy with. It performs a simple calculation of quantity on hand multiplied by current cost price. The previous system used an 'average' purchase price. As costs are inevitably increasing, the valuation of stock which we have held for several years, having purchased at a much lower price, will now be reported as much higher than the actual cost.
As I understand it, we will effectively have to pay CT on this growth in stock value. In reality the stock is aging and should technically have a lower value (depreciating). It is not an 'investment'.
Apart from the depreciation aspect, we've had to increase the selling price of affected items (we would have to pay the current, higher cost price to replace our older shelf stock) this means higher CT liability at year end.
In summary, if we use our system's stock valuation calculation we will be liable for CT on an increase in value which should actually be depreciation.
Overall this seems unfair. I'm hoping for some advice as to how we can more fairly calculate our year end stock valuation.
Thanks
Rob
Last financial year we used a new accounting and stock management system which calculates stock valuation in a way that I'm not happy with. It performs a simple calculation of quantity on hand multiplied by current cost price. The previous system used an 'average' purchase price. As costs are inevitably increasing, the valuation of stock which we have held for several years, having purchased at a much lower price, will now be reported as much higher than the actual cost.
As I understand it, we will effectively have to pay CT on this growth in stock value. In reality the stock is aging and should technically have a lower value (depreciating). It is not an 'investment'.
Apart from the depreciation aspect, we've had to increase the selling price of affected items (we would have to pay the current, higher cost price to replace our older shelf stock) this means higher CT liability at year end.
In summary, if we use our system's stock valuation calculation we will be liable for CT on an increase in value which should actually be depreciation.
Overall this seems unfair. I'm hoping for some advice as to how we can more fairly calculate our year end stock valuation.
Thanks
Rob
